Webinar - From DNA to Therapy: Exploring Plasmid Applications, LVV Manufacturing, and Regulatory Insights Join us on April 22ⁿᵈ for an exclusive webinar on Cell and Gene Therapy (CGT) development! Gain expert knowledge on optimizing plasmid and LVV production timelines, ensuring regulatory compliance, and navigating IND and BLA applications across global agencies. Don’t miss this opportunity to stay ahead in the evolving CGT landscape! Register Now Luffy ChenHead of Plasmid PD and Production Dept., ProBio Yucheng LuSr. ScientistVirus Manufacturing Dept., ProBio Tina YuSr. Director Regulatory Affairs Dept., ProBio Time Topic 14:00-14:45 Plasmid Applications and Production Challenges in Cell and Gene TherapyLuffy Chen, Head of Plasmid PD and Production Dept., ProBio Plasmid applications in cell and gene therapy Develop new process to shorten plasmid production timeline and cut cost Understand how the industry is changing and where the challenges and opportunities are for the sector 14:45-15:30 Lessons from IND Clearances in CAR-T Development: From LVV Process Development to INDYucheng Lu, Sr. Scientist, Virus Manufacturing Dept., ProBio Performance of different LVV packaging systems Process optimization and scaling up Tech transfer and change control strategy Case sharing 15:30-16:15 CMC Regulatory Considerations for CGT ProductsTina Yu, Sr. Director of Regulatory Affairs Dept., ProBio Key principles in CGT development CMC considerations for IND application: ensuring safety and consistent quality Comparing IND review practices: FDA vs. NMPA Work scope for BLA application Find more available materials Related service: Plasmid manufacturing, LVV manufacturing « Previous Page ProBio Announces New Executive Appointments Next Page ProBio Accelerates Chimagen's Global Market Expansion, Paving the Way for Innovative Antibody Therapy » Contact us Phone: 1-877-436-7274 (Toll-Free); 1-732-885-9188 Fax: 1-732-210-0262
Latest WebinarsFrom DNA to Therapy: Exploring Plasmid Applications, LVV Manufacturing, and Regulatory InsightsStrategies and Solutions for mRNA Therapeutics and Personalized MedicinesUnlocking Affordability: Cell Therapy Development Strategies to Expand Patient AccessmRNA One-stop Solution: Plasmid, Linearized DNA, IVT-mRNA, mRNA-LNP and QC sharingFind More Cell & Gene Therapy Categories